Oragenics, Inc. is a U.S. company that develops antibiotics for infectious diseases, as well as vaccines for the novel coronavirus. It has a license agreement with Noachis Terra and a collaboration agreement with Precigen, Inc. and ILH Holdings, Inc. The company is based in Tampa, Florida.